Skip to content

Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease

Randomized Controlled Trial Comparing Surgical Outcomes Following PCNL Under Ultrasound Control and PCNL Under Fluoroscopic Control in the Treatment of Kidney Stones

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04606758
Enrollment
150
Registered
2020-10-28
Start date
2020-11-30
Completion date
2022-12-31
Last updated
2020-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Calculi, Kidney Diseases, Kidney Stone, Ureteral Calculi, Urolithiasis

Brief summary

Randomized comparison of patient outcomes following fluoroscopic guided PCNL versus ultrasound-guided PCNL.

Detailed description

This study is a randomized controlled trial that compares the operative outcomes and complications of fluoroscopic guided-percutaneous nephrolithotomy versus ultrasound-guided PCNL for renal stones. This study will be a prospective randomized controlled clinical trial with patients who have already agreed to undergo PCNL. Patients will be randomized at a 1:1 ratio to receive either PCNL under fluoroscopic guidance or PCNL under ultrasound guidance. Patients will be asked to complete pre-operative, and postoperative quality of life questionnaires, and to allow the collection of one additional vial of blood for measurement of factors associated with inflammation.

Interventions

PROCEDUREPCNL under fluoroscopic control

Patients receive standard of care treatment for their urolithiasis using standard PCNL under fluoroscopic guidance

PROCEDUREPCNL under ultrasound control

Patients receive standard of care treatment for their urolithiasis using standard PCNL under US guidance

Sponsors

Medipol University
CollaboratorOTHER
Astana Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients planned for PCNL at participating institution * Patients of all ethnic backgrounds * Stone size over 10 mm in diameter and a density over 900 Hounsfield units * Patients with a large calculus in the upper third of the ureter

Exclusion criteria

* Pregnancy * infectious disease of the genitals; * conditions that violate the configuration of the kidneys (curvature of the spinal column) * anomalies in the development of the kidneys with impaired configuration and position of the kidneys (horseshoe kidney, bisque kidney, S-shaped kidney, L-shaped kidney, lumbar dystopia, iliac dystopia, pelvic dystopia) * presence of nephrostomy drainage in the target kidney; * urethral stricture or other reason leading to the inability to carry out ureteral catheterization; * other conditions that are contraindications to surgical treatment, such as uncontrolled diabetes mellitus, acute cardiovascular conditions, liver failure, alcoholism, and drug addiction; * patients who are unable to understand the purpose of the study or refuse further follow-up observation and instructions after treatment; * patients with a history of mental illness; * participation in another research that interferes with this research; * acute renal failure; * dissecting aortic aneurysm; * acute hypertensive encephalopathy; * heavy arterial bleeding; * myocardial infarction less than six months before enrollment in the study; * Stroke less than six months before enrollment in the study; * Insufficiency of blood circulation III-IV New York Heart Association class; * Severe rhythm and conduction disturbances; * Increase in the level of liver transaminases by more than three times;

Design outcomes

Primary

MeasureTime frame
Blood loss as estimated by postoperative decreases in haemoglobinPost-operative day 1

Secondary

MeasureTime frameDescription
Surgical outcomes6 monthsOutcome measures by using the clavien dindo classification system
Asses the easiness of accessibility of the targeted stoneIntraoperativelyOutcome measures by counting numbers of puncture trial
The Puncture fluoroscopy screening timeIntraoperativelyassessed on the monitor of C-Arm.

Contacts

Primary ContactUlanbek Zhanbyrbekuly
ulanbek.amu@gmail.com+77071652019

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026